Basic Information | Post buying leads | Suppliers |
Name |
Uranium Nitrate |
EINECS | N/A |
CAS No. | 15905-86-9 | Density | g/cm3 |
PSA | 275.52000 | LogP | 1.13640 |
Solubility | N/A | Melting Point |
N/A |
Formula | HN O3 . x U | Boiling Point | 83°Cat760mmHg |
Molecular Weight | 1729.02 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | A poison by intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic vapors of NOx and U. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | A poison. | |
Synonyms |
Uraniumnitrate |
Chemistry informtion about Uranium Nitrate (CAS NO.15905-86-9) is:
IUPAC Name: Uranium Tetranitrate
Synonyms: Nitric Acid, Uranium Salt
MF: N4O12U
MW: 486.048510 g/mol
Boiling Point: 83 °C at 760 mmHg
Enthalpy of Vaporization: 37.72 kJ/mol
Vapour Pressure: 49.8 mmHg at 25°C
Following is the molecular structure of Uranium Nitrate (CAS NO.15905-86-9) is:
Safty information about Uranium Nitrate (CAS NO.15905-86-9) is:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | subcutaneous | 2mg/kg (2mg/kg) | kidney, ureter, and bladder: "changes in tubules (including acute renal failure, acute tubular necrosis)" kidney, ureter, and bladder: other changes in urine composition kidney, ureter, and bladder: other changes | American Journal of the Medical Sciences. Vol. 178, Pg. 449, 1929. |
mouse | LD50 | intravenous | 49mg/kg (49mg/kg) | behavioral: somnolence (general depressed activity) behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 315, 1959. |
mouse | LDLo | intraperitoneal | 2gm/kg (2000mg/kg) | peripheral nerve and sensation: spastic paralysis with or without sensory change behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 315, 1959. |
mouse | LDLo | subcutaneous | 2gm/kg (2000mg/kg) | peripheral nerve and sensation: spastic paralysis with or without sensory change behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 315, 1959. |
rabbit | LD50 | subcutaneous | 1500ug/kg (1.5mg/kg) | behavioral: convulsions or effect on seizure threshold behavioral: food intake (animal) gastrointestinal: "hypermotility, diarrhea" | Journal of Industrial Hygiene and Toxicology. Vol. 31, Pg. 301, 1949. |
rabbit | LDLo | intravenous | 10mg/kg (10mg/kg) | lungs, thorax, or respiration: cyanosis lungs, thorax, or respiration: respiratory stimulation | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 315, 1959. |
rat | LDLo | intraperitoneal | 100mg/kg (100mg/kg) | Nagoya Journal of Medical Science. Vol. 24, Pg. 133, 1961. | |
rat | LDLo | subcutaneous | 4gm/kg (4000mg/kg) | peripheral nerve and sensation: spastic paralysis with or without sensory change behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 315, 1959. |
A poison by intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic vapors of NOx and U.